A phase I study of temozolomide and lapatinib combination in patients with recurrent high-grade gliomas.
about
CUSP9* treatment protocol for recurrent glioblastoma: aprepitant, artesunate, auranofin, captopril, celecoxib, disulfiram, itraconazole, ritonavir, sertraline augmenting continuous low dose temozolomide.Recurrent malignant gliomas.Report of safety of pulse dosing of lapatinib with temozolomide and radiation therapy for newly-diagnosed glioblastoma in a pilot phase II study.Recent advances in targeted therapy for glioblastoma.Investigational new drugs for brain cancer.
P2860
A phase I study of temozolomide and lapatinib combination in patients with recurrent high-grade gliomas.
description
2013 nî lūn-bûn
@nan
2013年の論文
@ja
2013年学术文章
@wuu
2013年学术文章
@zh
2013年学术文章
@zh-cn
2013年学术文章
@zh-hans
2013年学术文章
@zh-my
2013年学术文章
@zh-sg
2013年學術文章
@yue
2013年學術文章
@zh-hant
name
A phase I study of temozolomid ...... recurrent high-grade gliomas.
@en
A phase I study of temozolomid ...... recurrent high-grade gliomas.
@nl
type
label
A phase I study of temozolomid ...... recurrent high-grade gliomas.
@en
A phase I study of temozolomid ...... recurrent high-grade gliomas.
@nl
prefLabel
A phase I study of temozolomid ...... recurrent high-grade gliomas.
@en
A phase I study of temozolomid ...... recurrent high-grade gliomas.
@nl
P2093
P2860
P1433
P1476
A phase I study of temozolomid ...... recurrent high-grade gliomas.
@en
P2093
Despina Televantou
George Pentheroudakis
Sofia Chrisafi
Sofia Lambaki
Vasilios Karavasilis
Vassiliki Kotoula
P2860
P2888
P304
P356
10.1007/S00415-012-6812-Z
P577
2013-01-05T00:00:00Z
P6179
1028459988